ReviewThe Journal of clinical endocrinology and metabolism2022

Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease.

Andrea Lora Kossler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.